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Summary
ADAR2 is a nuclear enzyme essential for GluR2
pre-mRNA editing atQ/R site-607, which gates Ca2+ en-
try through AMPA receptor channels. Here, we show
that forebrain ischemia in adult rats selectively re-
duces expression of ADAR2 enzyme and, hence, dis-
rupts RNA Q/R site editing of GluR2 subunit in vulner-
able neurons. Recovery of GluR2 Q/R site editing by
expression of exogenous ADAR2b gene or a constitu-
tively active CREB, VP16-CREB, which induces ex-
pression of endogenous ADAR2, protects vulnerable
neurons in the rat hippocampus from forebrain ische-
mic insult. Generation of a stable ADAR2 gene silenc-
ing by delivering small interfering RNA (siRNA) in-
hibits GluR2 Q/R site editing, leading to degeneration
of ischemia-insensitive neurons. Direct introduction
of the Q/R site edited GluR2 gene, GluR2(R607), res-
cues ADAR2 degeneration. Thus, ADAR2-dependent
GluR2Q/R site editing determines vulnerability of neu-
rons in the rat hippocampus to forebrain ischemia.
Introduction
Transient forebrain ischemia is caused by disruption of
blood flow supplying the brain because of cardiac arrest
or by reversible occlusion of an artery or by profound hy-
potension. A critical feature of the disease is a highly se-
lective pattern of neuronal loss in the central nervous
system (CNS); certain identifiable subsets of neurons
are severely damaged, including CA1 pyramidal neu-
rons in the hippocampus, cortical projection neurons
in layer three, and medium spiny neurons in the dorso-
lateral striatum, whereas other neurons in the brain re-
main intact (Pulsinelli et al., 1982; Schmidt-Kastner
and Freund, 1991; Wang et al., 2003a; Liu et al., 2004).
*Correspondence: youming@mail.ucf.edu
5 These authors contributed equally to this work.One step in this selective neuronal injury involves exces-
sive stimulation of glutamate receptor channels that
allow inflow of massive amounts of Ca2+ and Na+ in vul-
nerable neurons (Choi, 1995; Lipton, 1999; Lo et al.,
2003). Ca2+ overload can trigger several downstream le-
thal reactions including nitrosative stress (Iadecola
et al., 1997; Aarts et al., 2002, 2003), oxidative stress
(Kinouchi et al., 1991; Krajewski et al., 1999; Xiong
et al., 2004), and mitochondrial dysfunction (Fiskum
et al., 1999; Liu et al., 2003a; Bossy-Wetzel et al., 2004).
Glutamate plays an essential role in neural develop-
ment, excitatory synaptic transmission, and plasticity
(Choi, 1995; Lipton, 1999; Lo et al., 2003). Immediately
after ischemia, however, glutamate accumulates at the
extracellular space (Benveniste et al., 1984; Drejer
et al., 1985; Rossi et al., 2000), resulting in extensive
stimulation of its receptors that can eventually be neuro-
toxic (Simon et al., 1984; Choi, 1995). Glutamate
activates three classes of ionophore-linked postsynap-
tic receptors, namely N-methyl-D-aspartate (NMDA),
a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
(AMPA), and kainate receptors (Hollmann et al., 1991).
NMDA receptor toxicity is dependent on extracellular
Ca2+ and thus may reflect a large amount of Ca2+ influx
directly through the receptor-gated ion channels (Simon
et al., 1984; Choi, 1995). As most AMPA receptor chan-
nels have poor Ca2+ permeability (with exceptions, as
discussed below), injury may result primarily from indi-
rect Ca2+ entry through voltage-gated Ca2+ channels
(Weiss et al., 1990). Although excess stimulation of gluta-
mate receptors contributes to ischemic injury, blocking
them totally could be deleterious to animals and
humans because targeting these receptors would block
the physiological action of glutamate in noninjured neu-
rons as well. Thus, it may be fruitful to develop a practical
approach whereby the pathological effects of glutamate
in vulnerable neurons is selectively blocked, leaving the
physiological action of glutamate unaffected.
AMPA receptor channels constitute a major glutamate
receptor (GluR) subtype and are assembled from
GluR1–GluR4 subunits (Hollmann et al., 1991). The
Ca2+ permeability of AMPA receptor channels is deter-
mined by the GluR2 subunit (Hollmann et al., 1991;
Hume et al., 1991; Burnashev et al., 1992). In the adult
brain, nearly 100% of the mRNA encoding GluR2 is edi-
ted at the Q/R site corresponding to residue 607, where
the genomic glutamine (Q607) codon is converted to an
arginine (R) codon (Jonas and Burnashev, 1995; Geiger
et al., 1995). Edited GluR2(R) subunits form Ca2+-imper-
meable channels, whereas unedited GluR2(Q) channels
are permeable to Ca2+ flow. In most CA1 neurons, AMPA
receptor channels contain the GluR2(R) subunits and
thus are impermeable to Ca2+ entry (Jonas and Burna-
shev, 1995; Geiger et al., 1995). We have recently per-
formed whole-cell patch clamp recordings and deter-
mined the permeability of AMPA receptor channels to
Ca2+ (PCa/PNa) by calculating the shift in reversal poten-
tials of AMPA receptor-mediated excitatory postsynap-
tic currents (EPSCsAMPA) when the extracellular solution
is switched from high Na+ to high Ca2+. Our data showed
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the post-ischemic CA1 pyramidal neurons is 18-fold
greater than that in sham controls (Liu et al., 2004), dem-
onstrating that transient forebrain ischemia indeed in-
duces AMPA receptor channels to allow Ca2+ entry
into vulnerable CA1 pyramidal cells. Given that Ca2+-
permeable AMPA receptor channels are not only perme-
able to Ca2+ but are also highly permeable to Zn2+ (Koh
et al., 1996; Weiss and Sensi, 2000) and that a brief is-
chemic insult in rats induces Zn2+ accumulation in vul-
nerable neurons (Koh et al., 1996), it is suggested that
the expression of Ca2+-permeable AMPA receptor chan-
nels provides a route for toxic Zn2+ and/or Ca2+ entry
into vulnerable neurons.
The Ca2+ permeability of AMPA receptor channels is
dominated by the GluR2 subunit; an edited GluR2(R)
forms Ca2+-impermeable AMPA receptor channels,
whereas the unedited GluR2(Q) allows Ca2+ entry through
the channels (Hollmann et al., 1991; Hume et al., 1991;
Burnashev et al., 1992). Accordingly, expression of
Ca2+-permeable AMPA receptor channels in vulnerable
CA1 neurons after transient forebrain ischemia can re-
sult from reduced GluR2 gene expression and/or im-
paired GluR2 RNA editing at the Q/R site (i.e., relative
reduction in the GluR2[R] level). To distinguish these
possibilities, we have employed single-cell RT-PCR to
calculate GluR2 pre-mRNA editing versus GluR2 gene
expression in induction of Ca2+ permeability of AMPA
receptor channels in individual vulnerable neurons.
We have shown that transient forebrain ischemia selec-
tively disrupts GluR2 Q/R site editing in vulnerable neu-
rons and hence induces expression of Ca2+-permeable
GluR2(Q) receptor channels. We have also demon-
strated that impaired GluR2 Q/R site editing is closely
correlated with reduced expression of adenosine deam-
inase acting on RNA (ADAR2) gene, a nuclear enzyme
responsible for GluR2 Q/R site editing (Higuchi et al.,
1993, 2000; Rueter et al., 1995; Yang et al., 1995).
Thus, ADAR2-dependent GluR2 Q/R site editing deter-
mines vulnerability of neurons in the adult rat hippocam-
pus to transient forebrain ischemia.
Results
Forebrain Ischemia Impairs ADAR2-Dependent
GluR2 Q/R Site Editing in CA1 Pyramidal Neurons
We first determined the editing efficiency of GluR2 pre-
mRNA at Q/R site from individual cells in the rat hippo-
campus by single cell RT-PCR (see Experimental Proce-
dures). The cellular (including nucleus) RNA was isolated
with whole-cell patch pipettes after recordings of the
Ca2+/Na+ permeability ratio (PCa/PNa) of AMPA receptor
channels. The PCa/PNa values were calculated based on
the shifts of reversal potential of AMPA receptor-medi-
ated excitatory postsynaptic currents (EPSCsAMPA) after
a change of extracellular high Na+ to high Ca2+ (Figures
1A–1C). The extracted RNA from individual cells was
subjected to DNAase digestion and then reversely tran-
scribed (RT) into first-strand cDNA. GluR2 pre-mRNA
editing at Q/R site was measured by the difference in
the nested PCR products digested with the restriction
enzyme BbvI (Figure 1D). The editing efficiency ranged
from 7.1% to 97.9% in CA1 pyramidal neurons from
rats 12 hr after transient global ischemia (12hI, editing ef-ficiency = 39.1% 6 4.6%, n = 26 cells/eight rats) com-
pared with 96.9% 6 6.7% in sham controls (Figures
1D–1E, n = 18 cells/six rats). In other cell types in the hip-
pocampus of the 12hI rats, the Q/R site editing was not
altered (Figure 1E, editing efficiency = 98.2% 6 9.1% in
the dentate granule neurons and 95.4% 6 9.8% in CA3
pyramidal neurons), showing specific vulnerability of
the GluR2 Q/R site editing in CA1 pyramidal neurons.
Plot of the PCa/PNa values against the Q/R site editing
efficiency demonstrates that impaired GluR2 Q/R site
editing closely correlates with the Ca2+ permeability of
AMPA receptor channels (Figure 1F, g = 0.95). Consis-
tent with earlier reports that unedited GluR2 pre-mRNAs
are largely accumulated in the nucleus (Higuchi et al.,
1993, 2000), the undigested PCR products of the
GluR2 mRNA were found to be reduced in the postische-
mic CA1 pyramidal neurons (Figure 1G).
GluR2 pre-mRNA editing at Q/R site is catalyzed by
ADAR2 enzyme in the nucleus (Higuchi et al., 1993,
2000; Rueter et al., 1995; Yang et al., 1995). To determine
if impaired GluR2 Q/R site editing results from the defec-
tive expression of ADAR2 gene, we used quantitative
real-time PCR (qPCR) to analyze the ADAR2 mRNA in in-
dividual cells. Our data show that ADAR2 mRNA content
that was normalized to an internal reference GAPDH
mRNA was decreased by 63.3%6 4.6% in CA1 pyrami-
dal neurons of rats 12 hr after forebrain ischemia
(Figure 1H, n = 24 cells/eight rats). In contrast to reduced
ADAR2 mRNA, other members of the ADAR family
including ADAR1 and ADAR3 were not altered. By com-
parison of editing efficiency of GluR2 pre-mRNA at Q/R
site to the relative abundance of ADAR2 mRNA, we ob-
served that reduced ADAR2 mRNA expression was rel-
evant to the impaired GluR2 Q/R site editing in individual
vulnerable neurons (Figure 1I).
ADAR2b Expression Blocks Ca2+ Permeability
of AMPA Receptor Channels
To determine if a reduction of ADAR2 gene expression
contributes to the defected GluR2 Q/R site editing, we
expressed an exogenous ADAR2 gene in the hippocam-
pus of adult rats with eGFP as a reporter. Four alterna-
tively spliced ADAR2 isoforms (ADAR2a–ADAR2f) are
identified in rat brain (Slavov and Gardiner, 2002). We
focused on ADAR2b gene because it preferentially mod-
ifies the GluR2 pre-mRNA Q/R site (Rueter et al., 1995;
Slavov and Gardiner, 2002). We used chimeric form of
the recombinant adeno-associated virus vectors (rAAV2-
ADAR2b-eGFP) to express ADAR2b-eGFP in vivo. We
generated rAAV2-eGFP vectors as controls lacking
ADAR2 (rAAV2-eGFP) or encoding ADAR3-eGFP (rAAV2-
ADAR3-eGFP), which is ineffective for GluR2 Q/R site
editing (Chen et al., 2000). Each type of the infectious
particles (2 ml of 2 3 1013 genomic particles/ml) was in-
jected unilaterally into the hippocampus of rats at the in-
fusion rate of 0.1 ml/min. Fluorescence images show that
neurons expressing eGFP were present in the rat hippo-
campus 12 days after infection, indicating sustained ex-
pression of ADAR2b-eGFP gene (Figures 2A). Western
blots of the neuronal extracts with a polyclonal antibody
against eGFP show that ADAR2b-eGFP protein levels
reached a plateau 12 days after injection of the infec-
tious particles (Figure 2B). Expression of ADAR2b-
eGFP stimulated editing of GluR2 pre-mRNA at Q/R
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721Figure 1. Forebrain Ischemia Impairs ADAR2-Dependent GluR2 Q/R Site Editing in Vulnerable Neurons
(A) A representative IR-DIC image of whole-cell patch clamp recording in a hippocampal slice.
(B and C) I-V curves for EPSCsAMPA in high Na
+ (filled circles) or high Ca2+ (open circles) at holding potentials of 280 through +80 mV in CA1
pyramidal neurons from adult rats 12 hr after sham or forebrain ischemia (12hI). Traces are recordings at the holding potentials of 260, 240,
+40, and +60 mV, respectively. The PCa/PNa values are shown in bar graph (C, n = 16 cells/eight animals/group).
(D) A schematic representation (top) and Q/R site editing efficiency (bottom) in individual (circles) and group (mean 6 SEM, triangles) CA1 py-
ramidal neurons from sham (open symbols) or 12hI rats (filled symbols).
(E) Representatives show the PCR products of the undigested (top) and the digested (middle) GluR2 and an internal reference of the GAPDH
(bottom). Bar graph shows the editing efficiency in CA1 pyramidal neurons (PN, n = 26 cells/eight rats), GABAergic interneurons (IN, n = 14
cells/seven rats), astrocyte glia cells (GL, n = 10 cells/five rats), CA3 PN (n = 11 cells/five rats), and the dentate gyrus (DG) granule cells (GC,
n = 11 cells/five rats) from sham (lane 1) or 12hI rats (lane 2). Lane S indicates the molecular standards.
(F) The PCa/PNa values (in [C]) are plotted against the editing efficiency (in [D]) in CA1 pyramidal neurons from the 12hI rats.
(G) The undigested GluR2 mRNA levels, as normalized to an internal GAPDH mRNA levels in individual cells, are summarized in the bar graph.
A representative assay is shown in (E).
(H) The mRNA values of ADAR1, ADAR2, and ADAR3, as normalized to an internal reference (GAPDH mRNA) in individual cells (n = 24 cells/eight
rats), are summarized in the bar graph.
(I) Editing efficiency (in [D]) is plotted against ADAR2 mRNA (in [H]) in CA1 pyramidal neurons from the 12hI rats. In Figures 1C–1H, error bars
represent 6 SEM; asterisk, p < 0.01.
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Gene Restores GluR2 Q/R Site Editing in Vul-
nerable CA1 Neurons
(A) Representative images of the hippocam-
pus from rats 12 days after injection of the
rAAV2-ADAR2b-eGFP or the rAAV2-ADAR3-
eGFP vectors.
(B) Anti-eGFP blots of neuronal extracts from
the CA1 hippocampus 1 day (lane 1), 6 days
(lane 2), or 12 days (lane 3) after infection
with the rAAV2-eGFP, the rAAV2-ADAR2b-
eGFP, or the rAAV2-ADAR3-eGFP infectious
particles.
(C) GluR2 Q/R site editing in CA1 pyramidal
neurons without infection of virus particles
(control) or with expression of ADAR2b-
eGFP or ADAR3-eGFP from sham or 12hI
rats are shown in the bar graph.
(D) The rectification index (RI) = EPSCsAMPA
conductance at +60 mV/that at 260 mV in
CA1 pyramidal neurons without infection of
virus particles (a) or with expression of
ADAR2b-eGFP (b) or ADAR3-eGFP (c) from
sham or 12hI rats. Representative traces on
the graph are the averages of three sweeps
at holding potential of 260 mV and +60 mV,
respectively.
(E) The PCa/PNa ratios (n = 16 cells/eight rats/
group) in CA1 pyramidal neurons without in-
fection of virus particles (control) or with ex-
pression of ADAR2b-eGFP or ADAR3-eGFP
from sham or 12hI rats.
(F and G) Superimposed representative re-
cordings (F, left) and averaged (F, right) of
the miniature EPSCsAMPA in CA1 pyramidal
neurons from rats 12 hr after sham or fore-
brain ischemia (12hI). Bar graph (G) shows
the mean amplitudes (n = eight cells/group)
of the miniature EPSCsAMPA. In Figures 2C–
2G, error bars represent 6 SEM; asterisk,
p < 0.01.site in the postischemic CA1 pyramidal neurons (editing
efficiency = 95.9% 6 8.7%, Figure 2C, n = 18 cells/six
rats). We expressed ADAR3-eGFP as a control, which
showed catalytically inactive on GluR2 Q/R sit editing
in the postischemic CA1 pyramidal neurons (editing effi-
ciency = 41% 6 4.8%, n = 18 cells/six rats, Figure 2C).
We then determined the functional properties of AMPA
receptor channels with electrophysiological signals:
AMPA receptors containing the edited GluR2(R) show
a linear I-V relation, whereas receptors lacking the edi-
ted GluR2(R) display inward rectification (Hollmann
et al., 1991; Hume et al., 1991; Burnashev et al., 1992;
Liu et al., 2004). Our data show that EPSCsAMPA in the
12hI CA1 neurons expressing ADAR2-eGFP had a linear
I-V relation (RI = 0.96 6 0.083, n = 12 cells/six rats,
Figure 2D) with low Ca2+ permeability (the PCa/PNa =
0.116 6 0.009, n = 16 cells/eight rats, Figure 2E). It
should be noted that restoration of GluR2 Q/R site edit-
ing after expression of exogenous ADAR2b gene is as-
sociated with recovery of GluR2 protein expression. Ear-
lier studies showed that delivery of GluR2 subunit from
intracellular pools to cell surface is essential for expres-
sion of functional AMPA receptors at CA1 synapses (Shi
et al., 2001). Thus, expression of ADAR2b gene may alter
the strength of CA1 synapses. We then recorded the
miniature EPSCsAMPA and found that their mean ampli-
tudes in CA1 pyramidal neurons expressing ADAR2bwere statistically identical to those expressing ADAR3
(Figures 2F and 2G). These results are consistent with
previous reports that, although Ca2+-permeability of
AMPA receptor channels in the postischemic CA1 pyra-
midal neurons are altered, the mean amplitudes of the
EPSCsAMPA are not changed (Soundarapandian et al.,
2005), demonstrating that recovery of GluR2 Q/R site
editing induces expression of functional Ca2+-imperme-
able GluR2(R) receptor channels without changes of
synaptic strength.
Expression of ADAR2b Gene Is Neuronal Protective
To determine the putative neuronal protective effect of
exogenous ADAR2b, rats underwent a sham operation
or transient forebrain ischemia 12 days after injection
of the rAAV2-ADAR2b or control virus particles (rAAV2-
ADAR3). 6 days after ischemic insult (6dI), the sections
from rat dorsal hippocampus were stained with
Flouro-Jade (FJ) for damaged neurons and for NeuN
for survival neurons. The severe neuronal injury was ob-
served in the CA1 area of the dorsal hippocampus ex-
pressing ADAR3 (228 6 38 FJ-positive cells/0.2 mm2,
and 46 6 6 NeuN-positive cells/0.2 mm2, n = 11 rats)
(Figures 3A–3D), whereas most neurons in the rat hippo-
campus expressing ADAR2b survived (42 6 7 FJ posi-
tive cells/0.2 mm2; and 219 6 28 NeuN-positive cells/
0.2 mm2, n = 10 rats) (Figure 3E). Thus, expression of
GluR2 RNA Editing in Forebrain Ischemia
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mic injury.
Generation of Stable ADAR2 Gene Silencing
Transient forebrain ischemia in rats reduces ADAR2
gene expression in CA1 pyramidal neurons but not in
other cell types in the hippocampus. To determine
whether the maintenance of ADAR2 expression is re-
sponsible for neuronal resistance to ischemic injury,
we knocked down the endogenous ADAR2 gene with
small interfering RNA (siRNA) that specifically targets
to ADAR2 gene (R2siRNA). To deliver the R2siRNA into
adult rat hippocampus in vivo, we constructed the
rAAV2-U6/R2siRNA-CAG/eGFP vectors (Figure 4A). A
control vector was used to express a scrambled se-
quence (U6/SR2siRNA-CAG/eGFP, Figure 4A). 12 days
after perfusion of 2 ml of the infectious particles (2 3
1013 genomic particles/ml), rats were evaluated for ex-
pression of eGFP (Figure 4A). Expression of eGFP and
R2siRNA was under the control of independent pro-
moters and terminators, and neurons expressing eGFP
Figure 3. Expression of ADAR2b Gene Is Neuronal Protective
(A–D) Representative images show the hippocampus (left) and the
randomly selected CA1 areas (right) that were stained with the FJ
(green) or NeuN (red). The hippocampi without infection of the virus
particles (A and B) or with infection of the rAAV2-ADAR2b (C) or
rAAV2-ADAR3 (D) virus particles were from adult rats 6 days after
surgery for sham (A) or transient forebrain ischemia (6dI, [B]–[D]). Ar-
rowheads and arrows indicate cells with intact and pyknotic mor-
phology, respectively.
(E) The FJ- and NeuN-positive cells per 0.2 mm2 in the CA1 area. Er-
ror bars represent 6 SEM; asterisk, p < 0.01.may or may not coexpress R2siRNA. We then used
real-time PCR to examine ADAR2 mRNA levels, and a
reduction of ADAR2 mRNA was detectable as early as
6 days after perfusion of R2siRNA particles. By day 12,
ADAR2 mRNA was decreased by 65.2% 6 5.1% (n =
six assays/six rats, Figure 4B). To determine ADAR2
protein levels, we generated an antibody against a
GST fusion protein containing amino acids 504–527 of
ADAR2b. Affinity-purified anti-ADAR2 reacted with re-
combinant ADAR2b and ADAR1 proteins (Figure 4C).
Western blots of the dentate nuclear extracts show
that expression of R2siRNA reduced ADAR2 protein
levels (41.4% 6 4.7% of control; n = six assays/six
rats, Figure 4D). No further reduction of ADAR2 proteins
in the dentate gyrus expressing R2siRNA was observed
when animals were subjected to transient forebrain is-
chemia (Figure 4E). The rat hippocampus infected with
SR2siRNAvector (rAAV2-U6/SR2siRNA-CAG/eGFP)had
normal levels of ADAR2 mRNA and proteins at all
time points. Thus, rAAV2-delivered R2siRNA induces
stable ADAR2 gene silencing in the hippocampus of
adult rats. ADAR2 gene silencing is specific because
gene expression of ADAR1 and ADAR3 remained un-
changed.
ADAR2 Gene Silencing Induces Expression
of Ca2+-Permeable AMPA Receptor Channels
We then investigated the effect of ADAR2 gene silencing
on GluR2 pre-mRNA editing. GluR2 Q/R site editing in
the dentate gyrus of adult rats 12 days after delivery of
R2siRNA was decreased by 58.5% 6 5.2% (n = six as-
says/six rats), compared to expression of SR2siRNA
(Figure 5A). ADAR2 may induce GluR2 editing at the
R/G site, which alters desensitization of AMPA receptor
channels (Hollmann et al., 1991; Hume et al., 1991; Bur-
nashev et al., 1992; Higuchi et al., 2000). Our data show,
however, that the dentate granule neurons expressing
R2siRNA had partial editing of the R/G site (editing effi-
ciency = 45.2% 6 4.6%, n = six assays/six rats), which
did not differ from that expressing SR2siRNA (48.1% 6
5.3%, p > 0.01, n = six assays/six rats, Figure 5A), indi-
cating that knockdown of ADAR2 gene selectively dis-
rupts GluR2 Q/R site editing.
Failure of the GluR2 Q/R site editing reduces GluR2
mRNA levels because of accumulation of incompletely
processed GluR2 pre-mRNA in the nucleus (Higuchi
et al., 1993, 2000). Similar to this report, GluR2 mRNA
and protein levels in ADAR2-deficient dentate gyrus
were reduced by 57.8% 6 5.7% and 48.1% 6 5.9%, re-
spectively, compared to controls (Figures 5B and 5C,
n = six assays/six rats). Even though there was a reduc-
tion of GluR2 proteins in the total cell lysates (Figure 5C),
GluR2 receptor complexes in the postsynaptic density
(PSD) fraction (Figure 5D) from the dentate gyrus ex-
pressing R2siRNA did not differ from that expressing
SR2siRNA, suggesting that the numbers of functional
AMPA receptor channels at granule cell synapses may
be unchanged. This was investigated by recording the
miniature EPSCsAMPA from granule neurons in the den-
tate gyrus 12 days after expression of SR2siRNA or
R2siRNA (Figure 5E). The mean amplitudes of the minia-
ture EPSCsAMPA in granule cells expressing SR2siRNA
(78.66 6.9 pA, n = 12 cells/six animals) were comparable
to those expressing R2siRNA (83.1 6 7.8, n = 14 cells/
Neuron
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Silencing in the Adult Rat Hippocampus
(A) Representative images of the hippocam-
pus and the dentate gyrus from adult rats
12 days after injection of the rAAV2-U6/
R2siRNA-CAG/eGFP or the rAAV2-U6/
SR2siRNA-CAP-eGFP virus particles.
(B) The mRNA levels of ADAR1, ADAR2, and
ADAR3 in the dentate granule cells 1 day, 12
days, or 18 days after injection of SR2siRNA
or R2siRNA infectious particles are deter-
mined by real-time PCR assay and are sum-
marized in the bar graph (n = six assays/six
rats/group). Error bars represent 6 SEM; as-
terisk, p < 0.01.
(C) Polyclonal rabbit anti-ADAR2 recognizes
both ADAR2 and ADAR1 proteins. A GST fu-
sion protein containing amino acids 504–527
of mouse ADAR2b was used to generate
anti-ADAR2. Nuclear extracts from HeLa cells
without transfection of cDNAs (lane 1), with
transfection of cDNA encoding ADAR1 (lane
2), ADAR2b (lane 3), or both (lanes 4 and 5)
were blotted with anti-ADAR2 without (lanes
1–4) or with (lane 4) antigen (10 mg). Similar re-
sults were observed in each of four experi-
ments.
(D) Anti-ADAR2 blots of the dentate nuclear
extracts 1 day (lane 1) or 12 days (lane 12) af-
ter injection of the infectious particles. The protein levels of the ADAR1 (filled bars) and ADAR2 (open bars), as normalized to the ADAR1 lane 1 of
SR2siRNA (defined as 100), are summarized in the bar graph. Error bars represent 6 SEM; n = six assays/six rats/group; asterisk, p < 0.01.
(E) Anti-ADAR2 blots of the dentate nuclear extracts expressing SR2siRNA (lane 1) or R2siRNA (lane 2) from sham or 12 hr after forebrain ische-
mia (12hI). In this study, sham operation or transient forebrain ischemia was induced 12 days after infection with virus particles. The protein levels
of the ADAR1 (filled bars) and ADAR2 (open bars), as normalized to the ADAR1 lane 1 of SR2siRNA (defined as 100), are summarized in the bar
graph. Error bars represent 6 SEM; n = six assays/six rats/group; asterisk, p < 0.01.seven animals) (Figure 5F), demonstrating that knock-
down of ADAR2 gene induces relatively larger propor-
tions of GluR2 subunits incorporation into synapses
and likely facilitates insertion of GluR2(Q) subunits into
the cell surface (Greger et al., 2002, 2003). Thus, although
the total GluR2 proteins are reduced, the numbers of
synaptic AMPA receptor channels are unchanged. We
next analyzed Ca2+ permeability of synaptic AMPA re-
ceptor channels. We recorded the evoked EPSCsAMPA
at granule cell synapses by stimulation of the medial per-
forant fibers. AMPA receptor channels in dentate granule
neurons normally contain an edited form of GluR2(R) and
displayed a linear I-V relationship with low Ca2+ perme-
ability (PCa/PNa = 0.086 6 0.011, n = 12 cell/six rats,
Figure 5G). After expression of R2siRNA, AMPA receptor
channels had high Ca2+ permeability (PCa/PNa = 1.29 6
0.16, n = 18 cells/six rats, Figure 5G). Thus, knockdown
of ADAR2 gene inhibits GluR2 Q/R site editing and thus
expresses Ca2+-permeable AMPA receptor channels in
ischemia-insensitive neurons.
ADAR2 Gene Silencing Increases Neuronal
Sensitivity to Forebrain Ischemia
To determine if silencing ADAR2 gene makes neurons
vulnerable to ischemic insult, we performed three inde-
pendent experiments. First, we examined neuronal via-
bility in the hippocampus without ischemic insult. FJ
staining shows few injured neurons in sham rats 12
days after rAAV2-U6/R2siRNA injection, indicating that
knockdown of ADAR2 gene produces no pathological
lesions in the hippocampus of adult animals under phys-
iological condition (Figures 6A). This finding is consis-tent with earlier reports that expression of Ca2+ perme-
able AMPA receptor channels by genetic deletion of
the GluR2 gene in mice (Jia et al., 1996), or by direct in-
troduction of the GluR2(Q) gene in adult rats is not toxic
to neurons (Anzai et al., 2003; Liu et al., 2004), but is
compromised by a report that GluR2 anti-sense caused
selective cell death in the hippocampus (Oguro et al.,
1999).
Next, we examined if ADAR2 knockdown promotes is-
chemic degeneration of CA1 neurons. As demonstrated,
CA1 pyramidal neurons are gradually lost 3 days after
transient forebrain ischemia (3dI), and the majority de-
generate 6 days later (Wang et al., 2003a; Liu et al.,
2004). If knockdown of ADAR2 gene increases the re-
sponse of CA1 pyramidal neurons to ischemic insult,
we should see early CA1 cell death. Consistent with
this prediction, most CA1 neurons expressing R2siRNA
in 3dI rats were labeled with the FJ, whereas few neu-
rons expressing SR2siRNA were FJ positive (Figures
6A–6C). To determine if increased sensitivity of CA1
neurons with ADAR2 gene silencing to the injury is due
to reduced GluR2 Q/R site editing, we directly intro-
duced the GluR2(R) gene that is independent of Q/R
site editing in the ADAR2-deficient hippocampus (Fig-
ures 6A–6C). After expression of the GluR2(R) gene,
few damaged neurons were observed (586 9 FJ-labeled
cells/0.2 mm2, n = six rats /group).
Finally, we determined if ADAR2 silencing alters vul-
nerability of ischemia-insensitive neurons to forebrain is-
chemic insult, we examined degenerating neurons in
both CA3 area and the dentate gyrus. 6 days after tran-
sient forebrain ischemia (6dI), most ADAR2-deficient
GluR2 RNA Editing in Forebrain Ischemia
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(A) The editing efficiency of GluR2 Q/R, GluR2 R/G, GluR5 Q/R, and GluR6 Q/R sites in the dentate gyrus of rats 12 days after injection of the
infectious particles (n = six assays/six rats/group). (B) The representatives (top) and summaries (bottom) of the GluR1 and GluR2 mRNA levels.
(C and D) Representatives (top) and summaries (bottom) of the GluR1 and GluR2 protein levels in the whole cell lysates (C) or in the PSD fraction
(D) from the dentate extracts 1 day (lane 1) or 12 days (lane 12) after injection of the infectious particles. In bar graphs (filled bars, GluR1; open
bars, GluR2; and gray bars, b-actin in [C] or PSD-95 in [D]). Data are normalized to the SR2siRNA lane 1 (defined as 100).
(E) Sample traces of miniature EPSCsAMPA at 270mV were taken from granule cells in the dentate gyrus 12 days after expression SR2siRNA or
R2siRNA. The recordings were in the presence of 50 mM AP5 and 10 mM bicucculline.
(F) Averaged traces of miniature EPSCsAMPA from granule cells expressing SR2siRNA (a) or R2siRNA (b) are shown on the top. The mean am-
plitudes, 20%–80% rise time, and 65% decay time constants are summarized in bar graphs (n = 12 cells/six animals/group).
(G) The RI is plotted against the PCa/PNa values from granule cells expressing R2siRNA (filled circle) or SR2siRNA (open circle). Sample traces on
the top of the graph are the averages of three sweeps at membrane potentials of260,240, +40, and +60 mV, respectively. In Figures 5A–5G, error
bars represent 6 SEM; asterisk, p < 0.01.neurons in the CA3 area and the dentate gyrus had de-
generated, whereas few survival neurons were detected
(Figures 6D–6F). These results indicate that knockdown
of ADAR2 gene induces degeneration of neurons in the
CA3 area and the dentate gyrus that are otherwise insen-
sitive to ischemic injury. As reported before, ADAR2 tar-
gets not only GluR2 pre-mRNA but also induces pre-
mRNA editing of GluR5 and GluR6 subunits (Higuchi
et al., 2000; Vissel et al., 2001), which are reported to
be expressed in both CA3 area and the dentate gyrus
(Cossart et al., 1998; Vissel et al., 2001). Thus, unedited
GluR2 may act in concert with other unedited glutamatereceptor channels, particularly the GluR6 Q/R site editing
was found to be reduced in the ADAR2-deficient neurons
(Figure 5A), in degeneration of ADAR2-deficient neurons.
To investigate this idea, we expressed edited GluR2(R) in
ADAR2-deficient hippocampus with the pSFV(pd) vec-
tors. Similar to the results observed in CA1 area (Fig-
ure 6C), expression of the GluR2(R) gene protects the
ADAR2-deficient neurons in both CA3 area and the den-
tate gyrus from forebrain ischemic insult (Figure 6G).
These data indicate that ADAR2-dependent GluR2 Q/R
site editing determines vulnerability of neurons in the
rat hippocampus to forebrain ischemic insult.
Neuron
726Figure 6. ADAR2 Gene Silencing Increases
the Sensitivity of Neurons in the Hippocam-
pus to Ischemic Insult
(A–C) Representatives show the FJ-positive
(green) and NeuN-labeled (red) cells in CA1
area of the hippocampus from sham (A) or
3dI rats (B and C). In (C), the hippocampus
of rats was coexpressed with the GluR2(R)
or the GluR1 gene and the R2siRNA. In the
bar graph, SR2, SR2siRNA; R2, R2siRNA;
and data are mean6 SEM (n = six rats/group,
asterisk, p < 0.01).
(D–F) Representatives show hippocampus
(top), dentate gyrus (middle), and CA3 area
(bottom) from sham (D) or 6dI (E) rats. The
FJ-positive cells in the dentate gyrus and
CA3 area (n = eight rats/group) are summa-
rized in the bar graph (F).
(G) The FJ-positive cells in the ADAR2-defi-
cient dentate gyrus and CA3 area coexpress-
ing the GluR2(R) or GluR1 gene and the
R2siRNA from sham or 6dI rats. Data are
mean 6 SEM (n = six rats/group, asterisk,
p < 0.01).Expression of VP16-CREB Rescues
ADAR2 Degeneration
Recently, we have shown that expression of a con-
stitutively active CREB, VP16-CREB, increases GluR2
protein levels and also blocks Ca2+ permeability of
AMPA receptor channels in vulnerable CA1 neurons af-
ter transient forebrain ischemia (Liu et al., 2004). Subse-
quently, we wanted to determine if CREB regulates
GluR2 gene expression directly. We have then cloned
7 kb fragment of the 50-promoter region of the rat
GluR2 gene. By coexpression of the cloned GluR2 pro-
moter construct with VP16-CREB in HeLa cells, we
found that the VP16-CREB did not alter the GluR2 pro-
moter activity in vitro (data not shown), suggesting
that CREB may indirectly regulate GluR2 gene expres-
sion. An earlier study showed that inhibition of GluR2
RNA editing at Q/R site reduces GluR2 protein expres-
sion because of accumulation of unedited GluR2 pre-
mRNA in the nucleus (Higuchi et al., 2000). Consistent
with this report, we found that reduced GluR2 Q/R site
editing is closely correlated with reduced GluR2 mRNA
expression in vulnerable CA1 neurons (Figures 1E–1G).
We thus hypothesize that CREB regulates GluR2 gene
expression via regulation of GluR2 Q/R site editing. To
test this hypothesis, we first examined if reduced activ-
ity of CREB is responsible for impaired GluR2 Q/R site
editing, as well as for reduced GluR2 gene expression.
We then analyzed CREB activity by measurement ofphosphorylated CREB at Ser-133 (pCREBS133), an acti-
vated form of CREB, in the hippocampus. In this study,
the nuclear extracts were prepared from microdissected
CA1 area (Figure 7A). Western blots of the extracts show
a substantial decrease of pCREBS133 in the CA1 but not
in CA3 and the dentate gyrus of the hippocampus 12 hr
after forebrain ischemia (Figures 7A and 7B). These data
are consistent with earlier reports that CREB activity is
selectively reduced in vulnerable CA1 neurons (Tanaka
et al., 1999; Walton and Dragunow, 2000).
Next, we determined if reduced CREB activity is re-
sponsible for reduced ADAR2 gene expression. We ex-
pressed a constitutively active CREB, VP16-CREB
(Barco et al., 2002; Liu et al., 2004), in the rat hippocam-
pus with the rAAV2-VP16-CREB-eGFP vectors (Figures
7C and 7D). Western blots show that ADAR2 protein
levels in the postischemic CA1 neurons expressing
VP16-CREB were comparable to that in sham animals
(Figure 7E, n = six assays/six rats, p > 0.01). Similar to
the results with the recovery of ADAR2 enzyme expres-
sion in the postischemic CA1 neurons, expression of
VP16-CREB induced editing of the GluR2 pre-mRNA at
Q/R site (editing efficiency = 92.6% 6 4.2%) and hence
inhibited Ca2+ permeability of AMPA receptor channels
(PCa/PNa = 0.1026 0.014, n = 12 cells/six rats, Figure 7F).
Given that most neurons expressing VP16-CREB in the
CA1 area of the postischemic rats were not damaged
(Figure 7G, 32 6 6 FJ-positive cells/0.2 mm2, 218 6 33
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727NeuN-positive cells/0.2 mm2, n = six rats), we conclude
that CREB activation induces recovery of the ADAR2-
dependent GluR2 Q/R site editing, leading to the survival
of vulnerable CA1 neurons in the postischemic rats.
Requirement of ADAR2 for CREB Regulation
of GluR2 Q/R Site Editing
Expression of VP16-CREB may activate other target
genes of CREB in addition to the ADAR2 enzyme (Bonni
et al., 1999; Mantamadiotis et al., 2002). This was inves-
tigated by testing if knockdown of endogenous ADAR2
gene abolish CREB regulation of GluR2 Q/R site editing.
For this purpose, we constructed the pLenti6 vector
(pLenti6-U6/R2siRNA-CMV/VP16-CREB-eGFP vector,
Figure 8A) to simultaneously express the R2siRNA and
VP16-CREB genes in the adult rat hippocampus (Fig-
ure 8B). To control for the vector, we constructed
the pLenti6-U6/SR2siRNA-CMV/VP16-CREB-eGFP in-
fectious particles. The rat hippocampus was then in-
jected with 3 ml of the pLenti6 infectious particles (5 3
1012 genomic particles/ml). 12 days later, animals were
operated for sham or transient forebrain ischemia.
Western blots of the CA1 nuclear extracts show that
even though VP16-CREB was expressed, ADAR2 pro-
tein expression was dramatically reduced in the pres-
ence of R2siRNA (Figures 8C and 8D, n = five assays/
five rats/group). Similar to the results with a reduction
of ADAR2 enzyme expression, reduced GluR2 mRNA
levels with high PCa/PNa ratio (1.29 6 0.21, n = 14 cells)
were observed in vulnerable CA1 pyramidal neurons
with coexpression of VP16-CREB and R2siRNA (Figures
8E–8G). These results indicate that CREB regulates
GluR2 Q/R site editing and GluR2 protein expression
via induction of ADAR2 gene expression.
Discussion
We have identified a highly selective reduction of CREB-
dependent ADAR2 gene expression that results in the
defective GluR2 Q/R site editing in vulnerable CA1 py-
ramidal neurons after transient forebrain ischemia.
Expression of ADAR2 enzyme that edits the nuclear
GluR2 pre-mRNA at Q/R site protects vulnerable CA1
pyramidal neurons from forebrain ischemic insult. Gen-
eration of stable ADAR2 gene silencing being able to in-
hibit the GluR2 Q/R site editing induces degeneration of
the ischemia-insensitive neurons. Thus, our data have
demonstrated that ADAR2-dependent GluR2 Q/R site
editing fulfills both necessary and sufficient conditions
for neuronal survival in forebrain ischemic insult.
Transient forebrain ischemia reduces GluR2 mRNA
levels in hippocampal CA1 neurons (Gorter et al.,
1997). This observation led to the ‘‘GluR2 hypothesis,’’
which postulates that reduced GluR2 expression allows
Ca2+ entry through AMPA receptor channels (Pellegrini-
Giampietro et al., 1997; Oguro et al., 1999; Tanaka et al.,
2000). Our data show that recovery of the GluR2 Q/R site
editing by expression of VP16-CREB recovers the GluR2
protein levels (Figures 7), demonstrating that downregu-
lation of GluR2 gene expression occurring in vulnerable
CA1 pyramidal neurons after transient forebrain ische-
mia is due to the failure of GluR2 Q/R site editing. This
line of the conclusion is consistent with the previous re-
port that unedited GluR2 pre-mRNA is largely accumu-lated in the nucleus (Higuchi et al., 1993, 2000). Addition-
ally, our data show that although the total GluR2
proteins are altered in vulnerable CA1 neurons after
transient forebrain ischemia, the numbers of functional
AMPA receptor channels at CA1 synapses are un-
changed (Figures 2E–2G and 5E and 5F). These data in-
dicate that relatively larger proportions of GluR2 sub-
units are incorporated into synapses, likely reflecting
insertion of GluR2(Q) subunits into the cell surface
(Greger et al., 2002, 2003). Three earlier studies sug-
gested that GluR2 mRNA editing at the Q/R site was
not altered in the hippocampus of rats (Kamphuis
et al., 1995; Paschen et al., 1996) and gerbils (Rump
et al., 1996) after transient forebrain ischemia. In these
studies, however, the RNA was prepared from the hip-
pocampal tissue or from the gerbil CA1 region of the
whole hippocampus. The population of neurons in the
hippocampus is heterogeneous—and most neurons in
the dentate gyrus and CA3 area, for example, showed
complete GluR2 mRNA editing at Q/R site. Importantly,
vulnerable CA1 pyramidal neurons are located in the
dorsal part of the hippocampus only (Pulsinelli et al.,
1982; Schmidt-Kastner and Freund, 1991; Wang et al.,
2003a; Liu et al., 2004). Thus, the previously reported
GluR2 RNA editing in the CA1 tissue from the whole hip-
pocampus does not reflect changes in individual vulner-
able neurons in the dorsal hippocampus.
Glutamate toxicity is due largely to NMDA receptor
stimulation (Simon et al., 1984; Choi, 1995; Aarts et al.,
2002) because systematic administration of an NMDA
receptor antagonist protects CA1 pyramidal neurons
from ischemic injury (Simon et al., 1984). NMDA recep-
tors, however, are widely expressed in many types of
neurons, including ischemia-sensitive and insensitive
neurons in the brain (Kutsuwada et al., 1992; Monyer
et al., 1994). An earlier study revealed that CA3 pyrami-
dal neurons lacks NR2B subunit with expression of rela-
tive low levels of NR1 and NR2A subunit, compared to
CA1 pyramidal neurons (Watanabe et al., 1998; Kawa-
kami et al., 2003), suggesting that low density of
NMDA receptor channels may be responsible for the
less sensitivity of CA3 pyramidal neurons to ischemic in-
sult. A recent study shows that Ca2+ entry through
NMDA channels downregulates NMDA currents at CA3
pyramidal synapses, whereas it enhances NMDA cur-
rents in CA1 pyramidal neurons (Grishin et al., 2004),
leading to another suggestion that differential Ca2+-
dependent modulation of NMDA currents contributes
to the difference of NMDA toxicity between CA1 and
CA3 pyramidal neurons. These ideas, however, are un-
able to explain the difference of NMDA toxicity between
neurons in the dentate gyrus and CA1 area. NMDA re-
ceptor channels are heteromeric complexes consisting
of an essential NR1 subunit and one or more regulatory
NR2 subunits, NR2A–NR2D (Kutsuwada et al., 1992). We
have recently discovered that transient forebrain ische-
mia causes phosphorylation of NR2A at Ser-1232 (phos-
pho-Ser-1232) in rat CA1 neurons in vivo (Wang et al.,
2003a). We also determined that cyclin-dependent ki-
nase 5 (Cdk5) catalyzes Ser-1232 phosphorylation. Ex-
pression of a C-terminal peptide fragment of NR2A in-
hibits endogenous Cdk5 (or perturbs the Cdk5-NR2A
interaction) and protects CA1 neurons from the insult
(Wang et al., 2003a). Because Cdk5 regulation of NMDA
Neuron
728Figure 7. Expression of VP16-CREB Rescues ADAR2 Degeneration
(A and B) Forebrain ischemia reduces CREB activity in CA1 neurons only. Illustration (A) shows the microdissected CA1 and CA3 areas and the
dentate gyrus (DG) in a hippocampal slice. A representative (A) and summarized (B) the pCREBS133 and CREB levels in the rat hippocampus of
sham (lane 1) or 12 hr after transient forebrain ischemia (lane 2). The nuclear extracts were immunoprecipitated by mouse polyclonal anti-CREB
and then blotted with rabbit anti-pCREBS133 or anti-CREB, as indicated. The band intensities were normalized to the CREB in sham CA1 (defined
as 100, n = four assays/four animals/group).
(C and D) Representatives are images of the hippocampus from adult rats 12 days after infection with the rAAV2-VP16-CREB-eGFP (C) or rAAV2-
CREB-eGFP (D) virus particles.
(E) A representative (top) of anti-ADAR2 blots and a summary (bottom) of ADAR2 proteins (n = six assays/six rats/group) of the CA1 neuronal
extracts from sham (lane 1) or 12hI rats (lane 2) injected without (N) or with 2 ml of the rAAV2-VP16-CREB-eGFP or rAAV2-CREB-eGFP virus par-
ticles. In the bar graph, ADAR2 proteins were normalized to actin (C-2, defined as 100).
(F) The GluR2 mRNAs that were normalized to an internal reference GAPDH mRNA in individual CA1 pyramidal cells expressing VP16-CREB-
eGFP or CREB-eGFP from 12hI rats are plotted against the Q/R site editing efficiency. The GluR2 mRNA and the GluR2 Q/R site-editing efficiency
in CA1 pyramidal cells expressing VP16-CREB-eGFP or CREB-eGFP from sham and 12hI rats without (N) or with injection of the infectious par-
ticles (n = 12 cells/six rats) are summarized in the bar graph.
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Regulation of GluR2 Q/R Site Editing
(A) The pLenti6 vector for coexpression of
R2siRNA and VP16-CREB.
(B) A representative image of hippocampus
from a rat 12 days after infection with the
pLenti6-R2siRNA-CMV-VP16-CREB-eGFP vi-
rus particles. Higher magnification shows a -
selected CA1 area.
(C and D) A representative (C) of anti-ADAR2
blots and a summary (D) of ADAR2 proteins
(n = five assays/five rats/group) of the CA1
neuronal nuclear extracts from sham or 12hI
or 24hI rats infected with 3 ml of the pLenti6-
SR2siRNA-VP16-CREB-eGFP (lane 1, SR2/
VP16) or the pLenti6-R2siRNA-VP16-CREB-
eGFP (lane 2, R2/VP16) virus particles. In the
bar graph, ADAR2 proteins were normalized
to actin (C-2, defined as 100).
(E) The GluR2 mRNAs that were normalized to
an internal reference GAPDH mRNA in individ-
ual CA1 pyramidal cells from sham or 12hI or
24 hI rats (n = 14 cells/group).
(F) Bar graph shows summarized editing effi-
ciency in CA1 pyramidal neurons from sham
or 12hI or 24hI rats (n = 14 cells/group).
(G) Bar graph shows summarized PCa/PNa
values in CA1 pyramidal neurons from sham,
12hI, or 24 hI rats (n = 14 cells/group). In Fig-
ures 8D–8G, error bars represent 6 SEM; as-
terisk, p < 0.01.receptor channels occurs only in CA1 neurons but not in
other areas of the hippocampus, we suggested that co-
valent modulation of NMDA receptors by Cdk5 is the pri-
mary intracellular event underlying the selective injury of
CA1 pyramidal cells (Wang et al., 2003a). Cdk5 activa-
tion is initiated by Ca2+ entry through AMPA receptor
channels (Liu et al., 2004). Together, the failure of the
GluR2 Q/R site editing induces AMPA receptor channels
permeable to injurious Ca2+ entry. The initial Ca2+ rise
activates Cdk5 that induces prolonged opening of
NMDA receptor channels (Liu et al., 2004), which link
the neuronal nitric oxide synthase to generation of neu-
rotoxic product peroxynitrite (Fiskum et al., 1999; Liu
et al., 2003a; Bossy-Wetzel et al., 2004), resulting in neu-
ronal death.
To date, most clinical stroke trials targeting glutamate
receptors (AMPA or NMDA) have failed, possibly be-
cause receptor antagonists also block the physiological
actions of glutamate in noninjured neurons (Morris et al.,
1999). The present study shows that ADAR2-dependent
GluR2 Q/R site editing is an initial intracellular event that
gates glutamate receptor injurious signals in forebrain
ischemic insult, thereby suggesting practical strategy
for selective inhibition of the pathological effects gluta-mate receptors only. This approach should not affect
the physiological actions of glutamate receptors in non-
injured neurons.
Experimental Procedures
Constructs for Gene Expression and Gene Silencing
R2siRNA sequence (forward: 50-GGUGAAUGGCCAGGUUUUUtt-30;
reverse: 50-AAAAACCUGGCCAUUCACCtc-30) was provided by Am-
bion, Inc. (Austin, TX) and synthesized as two cDNA oligonucleo-
tides, which were cloned in pSilencer-U6 through BbsI/BstB sites.
The U6-R2siRNA cassette was re-cloned into rAVE construct con-
taining eGFP through ApaI/KpnI (GenDetect, New Zealand) or the
pLenti6 vector (Invitrogen, Carlsbad, California), creating a vector
rAVE-U6/R2siRNA-CAP/eGFP. A control vector was used to express
a scrambled R2siRNA (rAVE-U6/SR2siRNA-CAP/eGFP). The rAVE
plasmids were cotransfected with the AAV helper 2 into HEK293
cells to generate the rAAV2 virus particles. The constructs of
rAAV2-ADAR2b-eGFP, rAAV2-ADAR3-eGFP, and rAAV2-VP16-
CREB-eGFP were generated by cloning the cDNA encoding
ADAR2b gene (a gift from R.B. Emeson, Vanderbilt University School
of Medicine, Nashville) or ADAR3 (a gift from P.H. Seeburg, Max-
Planck-Institute for Medical Research, Heidelberg, Germany), or
VP16-CREB (a gift from Eric Kandel, Columbia University, NY) into
the rAAV2-eGFP vectors. Generation of pSFV(pd)-GluR2(R) and
pSFV(pd)-GluR1 vectors and packaging of recombinant virions ca-
pable of high infection of neurons in adult rats were described(G) The PCa/PNa values in CA1 pyramidal neurons from sham and 12hI rats without (N) or with infection of the VP16-CREB or the CREB virus par-
ticles (n = 12 cells/six rats).
(H) The FJ- and the NeuN-positive cells in the CA1 area of sham or 6dI rats injected without (N) or with the rAAV2-VP16-CREB or the rAAV2-CREB
infectious particles (n = six rats/group). In Figures 7C–7H, error bars represent 6 SEM; asterisk, p < 0.01.
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730previously (Wang et al., 2003a; Zhu et al., 2004; Liu et al., 2004). Ac-
tivated virus particles were coded by experimenters (P.L.P. and
S.H.L.). Other experimenters (M.M.S. and D.Y.Z.), who were unaware
of the coded particles, injected the particles (2 ml at 0.2 ml/min) into
each side of the dorsal hippocampus (3.1 mm posterior to bregma;
2.3 mm lateral to the midline; 2.9 mm below dura with as previously
described [Wang et al., 2003a; Zhu et al., 2004; Liu et al., 2004]).
Transient Forebrain Ischemia and Cell-Death Measurements
Transient forebrain ischemia was induced in rats 12 days after injec-
tion of the rAAV2 and pLenti6-based virus particles. Briefly, 80 6
5-day-old Sprague-Dawley rats were used. The bilateral vertebral
arteries were exposed, coagulated, and cut completely 12 hr before
the induction of ischemia. Ischemia was induced by bilaterally
occluding the common carotid arteries with aneurysm clips for
15 min, after which the clips were removed to restore cerebral blood
flow. Body temperature was maintained at 37ºC6 0.5ºC with heating
pads until the animals had recovered from surgery. Sham-operated
animals were treated identically, except that the carotid arteries
were not occluded. The experimenters (M.M.S. and D.Y.Z.) coded
all animals that had been subjected to sham operation or transient
global ischemia. Other experimenters, who were unaware of the ex-
perimental conditions, performed electrophysiological recordings
(X.F.Z., F.L., and L.L.), morphological staining (W.H.T. and D.Y.Z.),
cell counting (W.H.T.), and biochemical analysis (P.L.P., Y.Y.H.,
and S.H.L.). For each cell type, all labeled cells within the reticule
field (0.05 mm2 at the magnification used) were counted (determined
with the Imaging-Pro Plus, version 4.5, Media Cybernetics, Inc., MD)
throughout the depth of the section for four adjacent fields (begin-
ning at a random starting position in the CA1 area) of each section.
The number of cells was represented as per 0.2 mm2 in each section.
6 days after ischemia (6dI), animals were deeply anesthetized and
transcardially perfused with 0.9% NaCl saline followed by ice-cold
4% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS)
as described previously (Wang et al., 2003a; Liu et al., 2004). For
NeuN staining, the hippocampal sections (30 mm) were processed
with mouse anti-NeuN (1:1000; Chemicon) and reacted with conju-
gate-absorbed goat anti-mouse Cy-3 (1:200; Chemicon) to deter-
mine surviving neurons. Every other section was dried overnight
for Fluoro-Jade staining to determine degenerating neurons. The
slides were immersed for 3 min in 100% ethanol, for 1 min in 70%
ethanol, and for 1 min in distilled water and then incubated in a solu-
tion containing 0.01% Fluoro-Jade (Histo-Chem, Inc., Jefferson, AR)
and 0.1% acetic acid (1:10) for 30 min on a shaker. After three 10 min
washes, the slides were coverslipped. Labeled sections were visual-
ized with a confocal laser-scanning microscope (Olympus LSM-
GB200).
Single-Cell RT-PCR and Real-Time qPCR
After whole-cell patch clamp recordings of EPSCsAMPA, a second
gigaohm seal was formed on the same cell with a large patch pipette
(tip outer diameters of 2.5–3 mm with resistance of 0.5–1 MU when
filled with intracellular solution). The glass tubing for the recording
pipettes was heated (180ºC, 5 hr) immediately before use, and the in-
tracellular solutions were autoclaved. Cytoplasmic and nuclear con-
tents were harvested and expelled into a PCR tube with high positive
pressure visualized under infrared (IR) illumination and differential
interference contrast (DIC) optics. Control pipettes were advanced
into the slice. RNA from single cells was subjected to DNAase-I
(one unit DNAase I, Invitrogen). 4 ml mixture was RT into first-strand
cDNA with 50 U/ml of RNase H2 reverse transcriptase (1 ml; Super-
script II plus; Invitrogen) and 50 ng/ml hexamers, according to the
manufacturer’s instructions. The RT started with incubation at
25ºC for 10 min, followed by 37ºC for 60 min and was stopped by
heating to 70ºC for 10 min. 2 ml of cDNA was subjected first to
PCR in duplicate in a reaction mixture of 50 ml containing 200 mM
each primer, 1 mM dNTP Mix (Invitrogene), 5 ml of 103 PCR buffer
and 1 ml of Advantage 2 Polymerase mix. PCR products (0.5 mg) were
incubated at 37ºC for 12 hr with 103 restriction buffer and 2 U of BbvI
in a total volume of 20 ml and inactivated at 65ºC for 30 min. The PCR
products contain one (for GluR2 and GluR5) or two (for GluR6) intrin-
sic BbVI recognition sites. Thus, restriction digestion produced two
bands at 201 and 81 bp for unedited GluR2, at 341 bp and 115 bp
for edited GluR5, and three bands at 765 bp, 155 bp, and 25 bp foredited GluR6. Editing efficiency for GluR2 Q/R site editing was cal-
culated by the following equation: ([201 bp 2 81 bp]/201 bp) 3
100%. The band intensities were measured with GS-710 Calibrated
Imaging Densitometer (Bio-Rad). The following primers were used:
for the first PCR of GluR2, forward, 50-TCTGGTTTTCCTTGGG
TGCC-30; reverse, 50-AGATCCTCAGCACTTTCG-30. Nested PCR
primers were: forward, 50-GGTTTTCCTTGGGTGCCTTTAT-30; re-
verse, 50-ATCCTCAGCACTTTCGATGG-30; for the first PCR of
GluR5, forward, 50-TCTCCAAACCCTTCATGACCC-30; reverse, 50-
TTGATCCATCTCTAACCGCCC-30. For the nested PCR, forward,
50-TCAGCATTCTCTACCGGAAGC-30; reverse, 50-TTGATCCATCTC
TAACCGCCC-30; and for the first PCR of GluR6, forward, 50-
TGACCTTGCAGTTGCTCCACT-30; reverse, 50-CCCACTGCCACA
AAAACTGA-30; for the nested PCR, forward, 50-GGTCATCGACT
TTTCCAAGCC-30; reverse, 50-CCCACTGCCACAAAAACTGA-30.
Real-time RT-PCR approaches were used to determine ADAR2
mRNA levels. In brief, first-strand cDNA (20 ml total volume) was
used as a template for PCR with the TaqMan PCR Core Reagent
Kit (PE Applied Biosystems); primers, and TaqMan probes for
ADAR1-3 mRNAs were purchased from PE Applied Biosystems
(Foster City, CA) for ADAR2 (forward, 50-CTTTTTATCATCCCC
ACGCTG-30; reverse, 50-CACTGAACTCACACGGAAG-30, probe:
FAM-50-TGGACACACACGGAACAATGC-TANRA), ADAR1 (forward,
50-GATGCCTTTGCAGAACACCA-30; reverse, 50-TGCCCTTCTGAT
GCTGAGAACC-30, probe: FAM-50-CGCCACTTCCCTACCAGTTCC
TTG-TAMRA), and ADAR3 (forward, 50-TTGGGAAGGAGGCACCGA
CA-30; reverse, 50-CTTATTGGTTTCTCTGGGGCTG-30, probe: FAM-
50-TAGCTTGAGGGGGCACATGAAGA-TAMRA). Fluorescence emis-
sion at dye-specific wavelengths was monitored consecutively dur-
ing each PCR cycle. The target PCR was normalized to a reference
PCR (GAPDH). The targeted mRNA was expressed as percentage of
a reference mRNA in individual cells. The threshold cycle (Ct) was
determined in the exponential phase of the PCR. Specificity and
efficiency of the reaction conditions were optimized with cloned
rat ADAR cDNA. The primers and TaqMan probes were designed
for amplification of the ADAR2 mRNA, and no PCR products were
amplified when cloned ADAR1 or ADAR3 cDNA was used as PCR
target. The PCR conditions were optimized to amplify ADAR1,
ADAR2, and ADAR3 with similar efficiency by using serial dilutions
of cloned cDNA from 2 3 10218 to 8 3 10216 mol.
Electrophysiology
Hippocampal slices (350 mm) were prepared from rats 12 hr after
sham or transient forebrain ischemia (12hI), as described before
(Wang et al., 2003a, 2003b; Liu et al., 2003b, 2004). Slices in the re-
cording chamber were continuously superfused with artificial cere-
brospinal fluid (ACSF, 2 ml/min) saturated with 95% O2/5% CO2 at
30ºC 6 1ºC. The composition of ACSF was 124 mM NaCl, 3 mM
KCl, 1.25 mM NaH2PO4, 1.2 mM MgCl2, 2 mM CaCl2, 26 mM
NaHCO3, and 10 mM dextrose. For whole-cell patch-clamp record-
ings (tight seal >10 GU) from CA1 pyramidal cells, hippocampal sli-
ces were visualized with IR-DIC optics with an Axioskop 2FS equip-
ped with Hamamatsu C2400-07E optics. The EPSCsAMPA were
evoked by stimulation of the Schaffer-collateral fibers in the pres-
ence of 50 mM AP-5 and 10 mM bicuculline. The location of the stim-
ulus electrode (bipolar tungsten electrode with a tip of 0.18 mm) was
at the Schaffer collateral pathway about 60 mm from CA1 pyramidal
cell bodies. In the dentate gyrus, the stimulator was placed at the
medial perforant pathway. Stimulus intensities in all experiments
were set to 40% of the maximum response of EPSCs, which evoked
the EPSCs ofw150 pA at a holding potential of260 mV. Stimuli were
delivered at a frequency of 0.1 Hz. The intracellular solution con-
tained 142.5 mM Cs-gluconate, 7.5 mM CsCl, 10 mM HEPES,
0.2 mM EGTA, 2 mM Mg-ATP, 0.3 mM guanosine triphosphate,
and 0.1 mM spermine from Sigma (pH 7.4; 296 mOsm). The currents
were filtered at 5 kHz with a low-pass filter. Data were digitized at
a frequency of 10 kHz and stored online with the pclamp9 system
(Axon Instruments, Inc., Foster, CA). The input resistance and series
resistance in postsynaptic pyramidal cells were monitored with pre-
voltage steps (22 mV; 100 ms) at 5 min intervals throughout the pe-
riod of the experiment. Series resistance ranged from 8 to 11 MU. In-
put resistance was 3466 27 MU. The PCa/PNa ratio was determined
with the following equation: 0.25 aNa/aCa (exp[(2VrevCa 2 VrevNa)
F/RT] + exp[(VrevCa 2 VrevNa) F/RT]), in which PNa and PCa are the
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The aNa/aCa is the ion activities of Na
+ and Ca2+ in the extracellular
solution, and F, R, and T have their conventional meanings. Activity
coefficient was estimated by interpolation of tabulated values (0.75
for NaCl and 0.55 for CaCl2). The VrevCa and VrevNa values were cor-
rected for liquid junction potentials of 8.8 mV and 4.5 mV, respec-
tively. Because the permeability of AMPA receptor channels to
Na+ shows little difference to K+, we assumed that the PNa equals
the PK. The high-Ca
2+ solution contained 30 mM Ca2+Cl2, 105 mM
N-methyl-D-glucamine Cl, and 5.0 mM HEPES (pH 7.4); and the
high-Na+ solution contained 135 mM NaCl, 5.4 mM KCl, 1.0 mM
CaCl2, 1.0 mM MgCl2, and 5.0 mM HEPES (pH 7.4). Complete re-
placement of the bath solution with high-Ca2+ solution damaged
the cells in the slices; high-Ca2+ or high-Na+ solutions were applied
directly to recording cells via a double-barrel perfusion pipette at-
tached to a stepper motor (SF-77BLT, Warner Instruments, Ham-
den, CT) with delivery pressure pulses (128 kPa), and the slices
were continuously superfused with artificial cerebrospinal fluid. To
determine if this local perfusion effectively alters extracellular Ca2+
concentrations [Ca2+]e, we tested synaptic responses to alterations
of [Ca2+]e and showed corresponding changes of the reversal po-
tentials of evoked EPSCsAMPA in sham control CA1 pyramidal neu-
rons when [Ca2+]e was increased from 1.0 mM to 10 mM and
30 mM (Figure S1). These evoked EPSCs are mediated by AMPA re-
ceptors because they are completely blocked by 10 mM NBQX
(Sigma) in the local perfusion solution.
Nuclear Extraction and PSD Preparation and Western Blots
Hippocampi were removed from brain and sliced (w400 mm) with
Mcllwain tissue chopper at 4ºC. The dentate gyrus (or CA1 area, or
CA3 area, as illustrated in Figure 7A) was then microdissected
from the hippocampal slices visualized under Zeiss SteREO
DISCOVERY-V12 microscope. Briefly, hippocampal slices were
placed in the MS3 dissection chamber (Scientific System Design,
Inc., Mississuaga, Canada), which is mounted under Zeiss SteREO
DISCOVERY-V12 microscope. The slices in the chamber were con-
tinuously superfused with ice-cold (4ºC) ACSF (2 ml/min) saturated
with 95%O2/5%CO2 during dissection.
The dissected tissues from each animal (12 slices per rat) were
pooled and homogenized with Dounce homogenizer (12 strokes)
in five volumes (weight/volume) of ice-cold homogenizer buffer con-
taining (50 mM Tris-HCl [pH 7.6], 150 mM NaCl, 1% NP-40, 2 mM
EDTA, and proteinase inhibitor mixture from Sigma, 5 ml/100 mg tis-
sue). The extracts were spun at 1,400 3 g for 10 min. Supernatant
(S1) was saved and pellet (P1) was homogenized again with homog-
enizer (five strokes). After centrifugation at 7003 g, the supernatant
(S2) was pooled with S1 (whole-cell lysates). The P1 fraction was in-
cubated in homogenizing buffer containing 0.5% (w/v) NP-40 for
5 min, homogenized with a Dounce homogenizer (five strokes),
and centrifuged at 4,000 3 g for 10 min at 4ºC. The pellet was sus-
pended in nuclear extraction buffer containing 50 mM Tris-HCl
buffer (pH 7.5), 10% glycerol, 200 mM NaCl, 2 mM EDTA, 1 mM
EGTA, 0.1% SDS, 1% Triton X-100, 1% CHAPS, 0.5% NP-40, and
proteinase inhibitor mixture. Suspensions were kept on ice for
30 min, followed by centrifugation at 20,0003 g for 5 min and the su-
pernatant (nuclear extracts) was collected. Protein concentrations
were determined with the BCA protein assay kit (Pierce). The nuclear
extracts (20 mg protein) were then denatured with SDS sample buffer
and separated by 8% SDS-PAGE. Proteins were transferred onto ni-
trocellulose membranes with a Bio-Rad mini-protein-III wet transfer
unit overnight at 4ºC. Transfer membranes were then incubated with
blocking solution (5% nonfat dried milk dissolved in TBST buffer
[pH 7.5] [10 mM Tris-HCl, 150 mM NaCl, and 0.1% Tween 20]) for
1 hr at room temperature, washed three times, and incubated with
polyclonal rabbit primary antibody against ADAR2 (1:1000) or mouse
monoclonal anti-actin (C-2, 1:1000, Santa Cruz Technologies) for
1 hr at room temperature. Membranes were washed three times
with TBST buffer and incubated with the secondary anti-rabbit IgG
(1:1000) for 1 hr followed by washing four times. Signal detection
was performed with an enhanced chemiluminescence kit (Amer-
sham Bioscience, Arlington, IL). The bands were semiquantified by
‘‘the normalizing method’’ of the Densitometer Quantity One (Bio-
Rad). Rabbit polyclonal anti-ADAR2 was raised against the GST fu-
sion protein containing amino acids 504-528 (RLLTMSCSDKIARWNVVGIQGSLLS) of mouse ADAR2b, as described before (Wang et al.,
2003a). To determine if anti-ADAR2 specifically detect the ADAR2
protein, we expressed cDNA encoding ADAR1 or ADAR2b (gifts
from R.B. Emeson, Vanderbilt University School of Medicine, Nash-
ville) in HeLa cells (American Type Culture Collection, Manassas, VA)
grown in minimum essential medium supplemented with 10% fetal
bovine serum and 1% penicillin-streptomycin-glutamine in 6 well
plates. Cells were transfected with the ADAR1 cDNA (1.5 mg) or
ADAR2b cDNA (1.5 mg) with or without control cDNA (1.5 mg) by using
Lipofectamine 2000 (Invotrogen) according to the manufacturer’s in-
structions. Nuclear extracts (5 mg protein) from HeLa cells were then
prepared, as described above, and were subjected to 12% SDS-
PAGE and blotted with anti-ADAR2 (1:1000).
The nuclear extracts (500 mg of proteins) were incubated with
polyclonal mouse anti-CREB (2 mg, Santa Cruz Biotechnology) over-
night at 4ºC, followed by the addition of 40 ml of protein G-Sepharose
(Sigma) for 3 hr at 4ºC to examine pCREBS133 levels. Immunoprecip-
itates were washed four times with lysis buffer, denatured with SDS
sample buffer, and separated by 12% SDS-PAGE. Proteins were
transferred onto nitrocellulose membranes, as described above,
and blotted with rabbit anti-pCREB133 (1:1,000, Chemicon) or anti-
CREB (1:1,000, Chemicon).
For preparation of the PSD fraction, pooled S1 and S2 fractions
(whole cell lysates) were centrifuged at 14,000 3 g for 10 min. The
pellet (P2) was resuspended in sucrose buffer (0.32 M sucrose,
6 mM Tris [pH 8.0], and proteinase inhibitor mixture) with homoge-
nizer (five strokes). The P2 suspension was loaded onto a discontin-
uous sucrose gradient (0.85 M/1.0 M/1.2 M sucrose solution in 6 mM
Tris-HCl [pH 8.0]), followed by centrifugation for 2 hr at 82,500 3 g.
The synaptosome fraction between 1 M and 1.2 M sucrose was col-
lected with a syringe needle and diluted with equal volumes of Tris-
HCl buffer (6 mM Tris-HCl [pH 8.0] and 1% Triton X-100) and mixed
for 15 min. The suspension was centrifuged at 32,8003 g for 20 min.
The pellet (PSD) was collected. Protein concentrations determined
with the BCA protein assay kit (Pierce). The PSD proteins (5 mg) or
the whole cell lysates (20 mg) were denatured and separated by
8% SDS-PAGE, as described above. Proteins were then trans-
ferred onto nitrocellulose membranes, which were then incubated
with polyclonal rabbit anti-GluR1 (1:1,000, Chemicon), anti-
GluR2 (1:1,000, Zymed Technologies), polyclonal rabbit anti-b-actin
(1:2,000, AB3150, Chemicon), or monoclonal mouse anti-PSD-95
(1:2,000, Upstate Biotechnology) for 1 hr at room temperature. Mem-
branes were washed three times with TBST buffer and incubated
with the appropriate secondary antibodies (1:1,000) for 1 hr followed
by four washes. Signal detection was performed with an enhanced
chemiluminescence kit (Amersham Biosciences, Arlington, IL), as
described above.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/49/5/719/DC1/.
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